Artivion Inc (AORT)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $931.88M
Last updated: Nov 17, 2026 at 11:04 AM ET
Artivion Inc (AORT) Financials: Revenue, Profit and Cash Flow
Artivion reported revenue of $441.33M for the fiscal year ended Dec 31, 2025, up 13.6% from the year before. That year, net income was $9.77M with a net margin of 2.2%, operating cash flow was $39.88M and free cash flow was $839.00K. The quarter ended Sep 30, 2026 had revenue of $123.79M and net income of -$7.93M.
Revenue and Margins
The operating margin was 7.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $180.38M, a compound annual rate of 10.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $441.33M | +13.6% | 64.4% | 7.6% | 2.2% |
| Dec 2024 | $388.54M | +9.8% | 64.0% | 10.0% | -3.4% |
| Dec 2023 | $354.00M | +12.8% | 64.7% | 1.6% | -8.7% |
| Dec 2022 | $313.79M | +5.0% | 64.5% | 2.0% | -6.1% |
| Dec 2021 | $298.84M | +18.0% | 66.1% | 2.7% | -5.0% |
| Dec 2020 | $253.23M | -8.3% | 66.3% | 1.0% | -6.6% |
| Dec 2019 | $276.22M | +5.1% | 66.3% | 6.2% | 0.6% |
| Dec 2018 | $262.84M | +38.6% | 65.8% | 3.5% | -1.1% |
| Dec 2017 | $189.70M | +5.2% | 67.8% | 4.2% | 2.0% |
| Dec 2016 | $180.38M | N/A | 131.8% | 12.1% | 6.0% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441.33M | $388.54M | $354.00M | $313.79M | $298.84M | $253.23M | $276.22M | $262.84M | $189.70M | $180.38M |
| Cost of revenue | $157.10M | $139.76M | $124.83M | $111.27M | $101.32M | $85.44M | $93.21M | $89.86M | $61.06M | -$57.42M |
| Gross profit | $284.23M | $248.78M | $229.18M | $202.52M | $197.51M | $167.78M | $183.01M | $172.98M | $128.64M | $237.80M |
| Research and development | $30.99M | $28.45M | $28.71M | $38.88M | $35.55M | $24.21M | $22.96M | $23.10M | $19.46M | $13.45M |
| Operating income | $33.74M | $38.87M | $5.74M | $6.20M | $8.12M | $2.44M | $17.04M | $9.31M | $7.97M | $21.82M |
| Net income | $9.77M | -$13.36M | -$30.69M | -$19.19M | -$14.83M | -$16.68M | $1.72M | -$2.84M | $3.70M | $10.78M |
| EBITDA | $65.72M | $53.17M | $25.71M | $25.54M | $25.96M | $20.02M | $34.11M | $27.27M | $17.98M | $29.77M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $123.79M | $125.76M | $116.34M | $115.99M | $113.39M | $112.97M | $98.98M | $97.31M | $95.78M | $98.02M | $97.43M | $93.67M |
| Gross profit | $75.98M | $80.52M | $75.45M | $73.14M | $74.39M | $73.11M | $63.58M | $61.50M | $61.01M | $63.32M | $62.95M | $61.09M |
| Operating income | $2.95M | -$8.36M | $5.79M | $10.68M | $12.54M | $8.38M | $2.15M | $2.67M | $4.39M | $6.51M | $25.31M | $3.17M |
| Net income | -$7.93M | -$13.51M | $1.42M | $2.43M | $6.50M | $1.34M | -$505.00K | -$16.48M | -$2.29M | -$2.12M | $7.53M | -$3.98M |
Balance Sheet
As of Dec 2025, total debt of $235.80M exceeded cash and equivalents by $170.90M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $884.80M | $789.10M | $792.40M | $762.80M | $793.05M | $789.40M | $605.65M | $571.09M | $589.69M | $316.14M |
| Current assets | $358.08M | $290.08M | $280.67M | $247.33M | $247.70M | $234.59M | $187.39M | $179.17M | $179.28M | $147.23M |
| Cash and equivalents | $64.91M | $53.46M | $58.94M | $39.35M | $55.01M | $61.41M | $33.77M | $41.49M | $39.98M | $56.64M |
| Total liabilities | $436.56M | $512.90M | $510.62M | $478.47M | $492.32M | $460.69M | $319.96M | $296.02M | $312.63M | $107.16M |
| Short-term debt | $20.69M | $195.00K | $1.45M | $1.61M | $1.63M | $17.63M | $1.16M | $1.16M | $1.30M | $4.56M |
| Long-term debt | $215.11M | $314.15M | $305.53M | $306.50M | $307.49M | $290.47M | $214.57M | $215.72M | $218.24M | $67.01M |
| Shareholder equity | $448.23M | $276.20M | $281.78M | $284.33M | $300.73M | $328.71M | $285.70M | $275.07M | $277.06M | $208.98M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.04B | $1.07B | $883.16M | $884.80M | $857.66M | $838.39M | $791.16M | $789.10M | $803.14M | $789.54M | $784.01M | $792.40M |
| Total liabilities | $595.69M | $626.35M | $432.69M | $436.56M | $418.97M | $418.49M | $496.91M | $512.90M | $498.40M | $494.48M | $489.02M | $510.62M |
| Cash and equivalents | $48.40M | $77.32M | $55.76M | $64.91M | $73.43M | $53.48M | $37.69M | $53.46M | $56.17M | $55.02M | $51.12M | $58.94M |
| Shareholder equity | $446.40M | $445.58M | $450.47M | $448.23M | $438.69M | $419.90M | $294.25M | $276.20M | $304.74M | $295.06M | $294.99M | $281.78M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 2.1% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $39.88M | $22.24M | $18.82M | -$5.15M | -$2.58M | $12.37M | $15.83M | $9.88M | $10.80M | $19.72M |
| Capital expenditures | $39.04M | $11.19M | $9.75M | $10.71M | $13.09M | $7.33M | $8.07M | $5.79M | $6.63M | $6.20M |
| Free cash flow | $839.00K | $11.05M | $9.07M | -$15.87M | -$15.68M | $5.04M | $7.75M | $4.09M | $4.17M | $13.52M |
| Dividends paid | N/A | N/A | N/A | N/A | $3.76M | $2.43M | $4.76M | N/A | N/A | N/A |
| Investing cash flow | -$42.04M | -$28.19M | -$502.00K | -$10.71M | $5.66M | -$73.13M | -$23.94M | -$6.71M | -$171.05M | -$78.91M |
| Financing cash flow | $11.28M | $2.20M | $865.00K | -$1.64M | -$12.22M | $93.61M | -$1.49M | -$2.56M | $143.25M | $73.43M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.56M | -$1.27M | $1.15M | $19.56M | $22.26M | $15.01M | -$16.95M | $10.14M | $11.46M | $6.13M | -$5.49M | $10.84M |
| Capital expenditures | $13.01M | $10.75M | $8.00M | $27.51M | $4.61M | $3.29M | $3.64M | $1.43M | $3.64M | $2.51M | $3.61M | $2.67M |
| Free cash flow | -$17.57M | -$12.01M | -$6.85M | -$7.95M | $17.65M | $11.72M | -$20.59M | $8.71M | $7.82M | $3.62M | -$9.10M | $8.17M |
Frequently Asked Questions About AORT
What is Artivion's annual revenue?
Artivion reported revenue of $441.33M for the fiscal year ended Dec 31, 2025.
How fast is Artivion's revenue growing?
Revenue was up 13.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 12.0%.
Is Artivion profitable?
Yes. Artivion reported net income of $9.77M for the fiscal year ended Dec 31, 2025, with a net margin of 2.2%.
How much free cash flow does AORT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $39.88M minus capital expenditures of $39.04M produced free cash flow of $839.00K.
How much debt does Artivion have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $215.11M, short-term debt of $20.69M and cash and equivalents of $64.91M.
AORT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts